All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ASTC / Astrotech Corporation
|
|
|
|
|
|
|
|
| ANF / Abercrombie & Fitch Co.
|
|
|
|
|
|
|
|
| AVRO / AVROBIO, Inc.
|
|
|
|
|
|
|
|
| MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
| PRDS / Pardes Biosciences Inc
|
|
|
|
|
|
|
|
| US29079J2024 / Embark Technology Inc
|
|
|
|
|
|
|
|
| IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
| CRTX / Cortexyme Inc
|
|
|
|
|
|
|
|
| ADGI / Adagio Therapeutics Inc
|
|
|
|
|
|
|
|
| MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ORMP / Oramed Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| LSTA / Lisata Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
| CYTT / Cyteir Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BIL / SPDR Series Trust - SPDR Bloomberg 1-3 Month T-Bill ETF
|
|
|
|
|
|
|
|
| ELYM / Eliem Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CALC / CalciMedica, Inc.
|
|
|
|
|
|
|
|
| PASG / Passage Bio, Inc.
|
|
|
|
|
|
|
|
| FBRX / Forte Biosciences, Inc.
|
|
|
|
|
|
|
|
| ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
| MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
| AVIR / Atea Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SGOV / iShares Trust - iShares 0-3 Month Treasury Bond ETF
|
|
|
|
|
|
|
|
| RVP / Retractable Technologies, Inc.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| TLYS / Tilly's, Inc.
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
| CARM / Carisma Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
|
|
|
|
|
| GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| TALS / Talaris Therapeutics Inc
|
|
|
|
|
|
|
|
